Quick Takeaways
- FMR LLC filed SCHEDULE 13G/A for ATEA PHARMACEUTICALS INC COMMON STOCK (AVIR).
- Disclosed ownership: 6.7%.
- Date of event: 30 Jun 2025.
FMR LLC - 30 Jun 2025 SCHEDULE 13G/A Report for ATEA PHARMACEUTICALS INC COMMON STOCK (AVIR)
- Filing Manager
- FMR LLC
- Reporting Manager
- FMR LLC
- Symbol
- AVIR
- Shares outstanding
- 85,369,520 shares
- Disclosed Ownership
- 5,719,758 shares
- Ownership
- 6.7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 06 Aug 2025, 11:51:35 UTC
- Date of event
- 30 Jun 2025
- Next filing
- 05 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"FMR LLC disclosed 6.7% ownership in ATEA PHARMACEUTICALS INC COMMON STOCK (AVIR) on 30 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 06 Aug 2025, 11:51.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| FMR LLC | 6.7% | 5,719,758 | 5,717,317 | 0 | Richard Bourgelas | Duly authorized under Power of Attorney effective as of May 23, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* | |
| Abigail P. Johnson | 6.7% | 5,719,758 | 0 | 0 | Richard Bourgelas | Duly authorized under Power of Attorney effective as of May 23, 2023, by and on behalf of Abigail P. Johnson* |